BRO vs EDIT
Brown & Brown Inc (BRO) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the BRO and EDIT stock pages for the full models.
Not investment advice.